An Ontology for Description of Drug Discovery Investigations

Da Qi; Ross D. King; Andrew L. Hopkins; G. Bickerton; J. Richard; Larisa N. Soldatova

doi:10.2390/biecoll-jib-2010-126

An Ontology for Description of Drug Discovery Investigations

Da Qi, Ross D. King, Andrew L. Hopkins, G. Bickerton, J. Richard, Larisa N. Soldatova

Adran Cyfrifiadureg

Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

34 Dyfyniadau (Scopus)

165 Wedi eu Llwytho i Lawr (Pure)

Crynodeb

The paper presents an ontology for the description of Drug Discovery Investigation (DDI). This has been developed through the use of a Robot Scientist “Eve”, and in consultation with industry. DDI aims to define the principle entities and the relations in the research and development phase of the drug discovery pipeline. DDI is highly transferable and extendable due to its adherence to accepted standards, and compliance with existing ontology resources. This enables DDI to be integrated with such related ontologies as the Vaccine Ontology, the Advancing Clinico-Genomic Trials on Cancer Master Ontology, etc. DDI is available at http://purl.org/ddi/wikipedia or http://purl.org/ddi/home.

Iaith wreiddiol	Saesneg
Rhif yr erthygl	126
Nifer y tudalennau	13
Cyfnodolyn	Journal of integrative bioinformatics
Cyfrol	7
Rhif cyhoeddi	3
Dynodwyr Gwrthrych Digidol (DOIs)	https://doi.org/10.2390/biecoll-jib-2010-126
Statws	Cyhoeddwyd - 2010

NDC y CU

Mae’r allbwn hwn yn cyfrannu at y Nod(au) Datblygu Cynaliadwy canlynol

Mynediad at Ddogfen

10.2390/biecoll-jib-2010-126

dq_jib-126-2010.pdf

Cysylltiad parhaol

Dolen barhaus

Dyfynnu hyn

@article{3700465cfc524d3eaf5cf3d9047b010b,

title = "An Ontology for Description of Drug Discovery Investigations",

abstract = "The paper presents an ontology for the description of Drug Discovery Investigation (DDI). This has been developed through the use of a Robot Scientist “Eve”, and in consultation with industry. DDI aims to define the principle entities and the relations in the research and development phase of the drug discovery pipeline. DDI is highly transferable and extendable due to its adherence to accepted standards, and compliance with existing ontology resources. This enables DDI to be integrated with such related ontologies as the Vaccine Ontology, the Advancing Clinico-Genomic Trials on Cancer Master Ontology, etc. DDI is available at http://purl.org/ddi/wikipedia or http://purl.org/ddi/home.",

author = "Da Qi and King, {Ross D.} and Hopkins, {Andrew L.} and G. Bickerton and J. Richard and Soldatova, {Larisa N.}",

note = "Sponsorship: BBSRC",

year = "2010",

doi = "10.2390/biecoll-jib-2010-126",

language = "English",

volume = "7",

journal = "Journal of integrative bioinformatics",

publisher = "Informationsmanagement in der Biotechnologie e.V. (IMBio e.V.)",

number = "3",

}

TY - JOUR

T1 - An Ontology for Description of Drug Discovery Investigations

AU - Qi, Da

AU - King, Ross D.

AU - Hopkins, Andrew L.

AU - Bickerton, G.

AU - Richard, J.

AU - Soldatova, Larisa N.

N1 - Sponsorship: BBSRC

PY - 2010

Y1 - 2010

N2 - The paper presents an ontology for the description of Drug Discovery Investigation (DDI). This has been developed through the use of a Robot Scientist “Eve”, and in consultation with industry. DDI aims to define the principle entities and the relations in the research and development phase of the drug discovery pipeline. DDI is highly transferable and extendable due to its adherence to accepted standards, and compliance with existing ontology resources. This enables DDI to be integrated with such related ontologies as the Vaccine Ontology, the Advancing Clinico-Genomic Trials on Cancer Master Ontology, etc. DDI is available at http://purl.org/ddi/wikipedia or http://purl.org/ddi/home.

AB - The paper presents an ontology for the description of Drug Discovery Investigation (DDI). This has been developed through the use of a Robot Scientist “Eve”, and in consultation with industry. DDI aims to define the principle entities and the relations in the research and development phase of the drug discovery pipeline. DDI is highly transferable and extendable due to its adherence to accepted standards, and compliance with existing ontology resources. This enables DDI to be integrated with such related ontologies as the Vaccine Ontology, the Advancing Clinico-Genomic Trials on Cancer Master Ontology, etc. DDI is available at http://purl.org/ddi/wikipedia or http://purl.org/ddi/home.

U2 - 10.2390/biecoll-jib-2010-126

DO - 10.2390/biecoll-jib-2010-126

M3 - Article

C2 - 20375446

VL - 7

JO - Journal of integrative bioinformatics

JF - Journal of integrative bioinformatics

IS - 3

M1 - 126

ER -

An Ontology for Description of Drug Discovery Investigations

Crynodeb

NDC y CU

Mynediad at Ddogfen

Cysylltiad parhaol

Ôl bys

Dyfynnu hyn